Salivary testing of COVID-19: evaluation of serological testing following positive salivary results
dc.contributor.author | Caulley, Lisa | |
dc.contributor.author | Shaw, Julie | |
dc.contributor.author | Corsten, Martin | |
dc.contributor.author | Hua, Nadia | |
dc.contributor.author | Angel, Jonathan B. | |
dc.contributor.author | Poliquin, Guillaume | |
dc.contributor.author | Whelan, Jonathan | |
dc.contributor.author | Antonation, Kym | |
dc.contributor.author | Johnson-Obaseki, Stephanie | |
dc.date.accessioned | 2021-06-01T03:33:50Z | |
dc.date.issued | 2021-05-04 | |
dc.date.updated | 2021-06-01T03:33:50Z | |
dc.description.abstract | Abstract Background Salivary detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been proposed as an alternative to nasopharyngeal or oropharyngeal swab testing. Our group previously published a study demonstrating that both testing methods identified SARS-CoV-2 using polymerase chain reaction (PCR)-based detection methodology. We therefore conducted a follow-up study using antibody testing to evaluate the accuracy of saliva versus swabs for COVID-19 detection and the durability of antibody response. Methods Venous blood samples were collected from consenting participants and the presence of serum antibodies for SARS-CoV-2 was evaluated on a large, automated immunoassay platform by the Roche anti-SARS-CoV-2 qualitative assay (Roche Diagnostics, Laval Quebec). Individuals with a serum antibody cut-off index (COI) ≥ 1.0 were considered positive. Results In asymptomatic and mildly symptomatic patients with a previously positive standard swab and/or saliva SARS-CoV-2 PCR-test, 42 demonstrated antibodies with 13 patients positive by swab alone, and 8 patients positive by saliva alone. Conclusions Despite their status as ‘current standard’ for COVID-19 testing, these findings highlight limitations of PCR-based tests. | |
dc.identifier.citation | BMC Infectious Diseases. 2021 May 04;21(1):410 | |
dc.identifier.uri | https://doi.org/10.1186/s12879-021-06108-5 | |
dc.identifier.uri | http://hdl.handle.net/1993/35672 | |
dc.language.rfc3066 | en | |
dc.rights | open access | en_US |
dc.rights.holder | The Author(s) | |
dc.title | Salivary testing of COVID-19: evaluation of serological testing following positive salivary results | |
dc.type | Journal Article |